Search…

Lates News

16/04/2026

On April 16th, the world's first biased GLP-1 receptor agonist, Semaglutide injection, has started pre-booking on Alibaba Health. In February this year, Pfizer China and Hangzhou Xianwei Da Biotech announced a commercial strategic cooperation agreement on the new generation of biased GLP-1 receptor agonist Semaglutide injection. Currently, Semaglutide has completed strategic deployment for the dual indications of "diabetes + weight loss" (Securities Times).

Latest

3 m ago

Tencent's public relations director Zhang Jun announced today that Tencent officially released and open sourced the HY-World 2.0, a 3D world model. With just one sentence, users can generate 3D assets and directly import them into game production or physical simulation engines to achieve true playability and usability.

3 m ago

The refinery fire in Geelong, Victoria, Australia, has been extinguished.

4 m ago

The main contract of ethylene glycol rose by 3% intraday and is now trading at 5061.00 yuan.

4 m ago

The Guangdong Province Artificial Intelligence Application Docking Conference will be held on April 27th.

5 m ago

Japanese top diplomat on exchange rate issue: Japan has informed US Treasury Secretary Benson that Japan will update exchange rate trends as needed, and both sides have agreed to maintain close coordination on exchange rate issues.

See all latest